KZR-504 is a Highly Selective Inhibitor of Immunoproteasome Low Molecular Mass Polypeptide 2
A study from Henry W. B. Johnson discovered and described KZR-504 as a highly selective inhibitor of immunoproteasome low molecular mass polypeptide 2 (LMP2). Immunoproteasome is always expressed in nonhematopoietic…